Meters & Monitors

Blood Glucose Meters Next Current Continuous Monitors Next Comparison of Available Monitors Next
Various Future Monitors Next Improving Today's Meters Next Other Monitors Next Older Monitors

Future Monitoring

AiMedics Next A.Menarini Diagnostics Next Cybiocare OHD Next InLight Solutions Next Integrated Applications Next Kumetrix Next LighTouch Medical Next Optiscan Next Orsense Next Oxygen Biotherapeutics Next Sensors For Medicine and Science Next Sensys Medical Next Sentek Next Solianis Next Sontra Next SpectRx Next Visual Pathways

Key
Non-Invasive Non-Invasive
Semi-Invasive Semi-Invasive
Surgical Surgical
Continuous Continuous

AiMedics - Hypomon Semi-Invasive Monitoring, Measures glucose with a minimal breech of the outer skin layers. Continuous Monitoring, Measures glucose at a constant.

AiMedics, established in October 2001 as a commercial spin-off of the University of Technology, Sydney (UTS), specializes in non-invasive monitoring for various diseases, including diabetes, epilepsy, fatigue and Sudden Infant Death Syndrome.

One of AiMedics' primary focuses is the development of HypoMon®, a real-time, non-invasive, device that detects low blood glucose levels in people with diabetes who use insulin.

Hypomon™

GlucoDay Glucose Monitor
GlucoDay Glucose Monitor
Similar to the Sleep Sentry, the HypoMon® system attempts to non-invasively detect hypoglycemia symptoms in people with Type 1 and insulin-dependant Type 2 diabetes through contact with the skin. The system alerts when the blood glucose falls below 2.5 mmol/l (45 mg/dl). This alarm allows for the patient and/or care person to treat the hypoglycemia at an earlier stage. The system can be used to monitor glucose levels during the day and while you are sleeping. It will be a helpful device for people who cannot afford a continuous monitor but it is important to know that the device does not measure the actual blood sugar level. It only recognizes and measures the bodies responses to changes in BG levels.

The HypoMon® system includes a battery powered unit worn on your chest. This unit has four skin surface sensors that measure skin moisture and heart activity, two known symptoms of a low blood sugar. The readings from this chest unit are wirelessly sent to the receiver where the readings can be read. AiMedics has developed a system to take these readings and determine when hypoglycemia reaches a critical stage. .

Some drawbacks from the Sleep Sentry are present in this device as well. For instance, movement or sweat can trigger a false alarm. A particularly hot night or constant tossing and turning can result in many alarms throughout the night.

Timeline

In November 2009, Clinical Trial Results of the successful phase 2b study on the HypoMon® were presented at 9th Annual Diabetes Technology Meetin in San Francisco. You can see a full timeline of AiMedics accomplishments on their site.